Granted Patent
B2
US 8,013,116 · App. 12/320,707 · Granted Sep 6, 2011
Therapeutic peptides and method
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterized by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
Claims (3)
1. An isolated polypeptide consisting of SEQ ID No. 19.
2. An isolated polypeptide consisting of SEQ ID No. 7.
3. A composition comprising a polypeptide according to claim 1 and a pharmaceutically acceptable carrier.
Assignments (5)
MERGER
Recorded Mar 15, 2016
From: UNIVERSITE DE NANCY 1 HENRI POINCARE
To: UNIVERSITE DE LORRAINE
Reel/Frame 038087/0173 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Nov 24, 2015
From: NOVO NORDISK A/S
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 037133/0836 →
MERGER
Recorded Nov 24, 2015
From: UNIVERSITE HENRI POINCARE - NANCY I
To: UNIVERSITE DE LORRAINE
Reel/Frame 037157/0053 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 4, 2010
From: BIOXELL
To: NOVO NORDISK A/S
Reel/Frame 024513/0270 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 16, 2009
From: FAURE, GILBERT; GIBOT, SEBASTIEN; PANINA, PAOLA; PASSINI, NADIA
To: BIOXELL S.P.A.; UNIVERSITE HENRI POINCARE - NANCY I
Reel/Frame 022857/0991 →
Priority Claims (2)
GB 0426146.7
· Nov 29, 2004
· national
JP 2005-146848
· May 19, 2005
· national
Continuity (2)